小菜鸟
Lv1
80 积分
2020-12-09 加入
-
Traditional Chinese medicine syndrome differentiation and treatment by stages of Parkinson’s disease: study protocol for a multicentre, randomized, double-blind, placebo-controlled clinical trial
2小时前
待确认
-
Elranatamab: First Approval
1个月前
已完结
-
Antibody-based Phenotypic Screening – the Discovery of Oleclumab (MEDI9447)
1年前
已关闭
-
Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy
1年前
已完结
-
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
1年前
已完结
-
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
1年前
已完结
-
The safety and efficacy of rosuvastatin (Crestor®) on Japanese patients with hypercholesterolemia in post-marketing surveillance
1年前
已关闭
-
Female genital tumours : WHO Classification of Tumours, 5th Edition, Volume 4
1年前
已关闭
-
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial
2年前
已完结
-
Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
2年前
已完结